MAP will send a trained nurse to administer Sandostatin® LAR Depot injections for eligible patients.
For over 20 years, Sandostatin® LAR Depot has demonstrated strong evidence and has been a trusted medical therapy.
Sandostatin® LAR (octreotide acetate for injectable suspension) is a type of medical treatment for acromegaly called a somatostatin analogue
- Sandostatin® LAR Depot works by reducing both growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels
- In addition, Sandostatin® is the #1 prescribed somatostatin analogue in the world*†
Control You Can Trust
Sandostatin® offers you:
- Confidence and reliability of over 5 million doses of Sandostatin® LAR Depot administered worldwide*
- More than 20 years of strong evidence, established through over 800,000 patient-years of experience†
*For all approved indications.
†Combined use of immediate-release Sandostatin® Injection and Sandostatin® LAR Depot for all approved indications.
Remember to always report any symptoms as accurately as possible and discuss these with your doctor. This will ensure that you get the most appropriate dosage for your treatment.
Imagery supplied by Getty Images